Mark Senak writes in his Eye on FDA blog:

« The question of ROI [in pharma’s use of social media] has gone the way of the question of the shape of the planet.

It may still be worth having the discussion if for no other reason than to actually get grounded in your goals and objectives.  But in fact, we have all moved on and we are not turning back.

It is probably as much good to ask what the ROI is on social media in the same way you might ask what the ROI was on your press releases, your web site, or the electronic socket in wall.

In the end, it may not be a question about the return on investment as much as the cost of not doing business. »

See on www.eyeonfda.com